METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC)

Clinical trials for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC) explained in plain language.

Never miss a new study

Get alerted when new METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC) trials appear

Sign up with your email to follow new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

First-in-Human trial launches for promising new prostate cancer pill

Disease control Not yet recruiting

This is the first study in people to test the safety of a new oral drug called (R)-9bMS for advanced prostate cancer that has spread and stopped responding to standard hormone therapies. The main goal is to find a safe dose and see how well patients tolerate the medication. About…

Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC)

Phase: PHASE1 • Sponsor: TechnoGenesys, Inc. • Aim: Disease control

Last updated Mar 10, 2026 12:53 UTC

METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC)

Get alerted when new METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC) trials appear

First-in-Human trial launches for promising new prostate cancer pill